Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02402933 · ClinicalTrials.gov registry record · Phase 3

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

A Phase 3 study of Diabetes Mellitus and Hypoglycemia, sponsored by Eli Lilly and Company.

Completed
Registry status
Phase 3
Development phase
26
Enrollment target
3
Study locations

NCT02402933 is a Phase 3 study of Diabetes Mellitus and Hypoglycemia that has completed, run by Eli Lilly and Company. The registered enrollment target is 26 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02402933, a Phase 3 study of Diabetes Mellitus and Hypoglycemia, has completed, sponsored by Eli Lilly and Company.

COMPLETED
Registry status
Phase 3
Development phase
26 participants
Enrollment target
3
Study locations

Study Summary

Up to fifty (50) children and adolescents with type 1 diabetes (T1D) aged 4 to ˂18 years at time of enrolment will be selected for inclusion in the study. The target is to obtain treatment response and user-experience data following use of Nasal Glucagon (LY900018) in treating episodes of hypoglycemia.

Conditions Studied

Diabetes Mellitus Hypoglycemia

Interventions

  • DRUG Nasal Glucagon

Study Locations (3)

Florida

  • Private Clinic - Tallahassee

Maryland

  • Private Clinic - Baltimore

Massachusetts

  • New England Diabetes and Endocrinology Center (NEDEC) - Waltham

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2015-03
Est. Completion 2015-08
Phase Phase 3

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02402933

The ClinicalTrials.gov registry entry for NCT02402933 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Nasal Glucagon is the first listed.

NCT02402933 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02402933 about?

NCT02402933 is a clinical study titled "Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents". Up to fifty (50) children and adolescents with type 1 diabetes (T1D) aged 4 to ˂18 years at time of enrolment will be selected for inclusion in the study. The target is to obtain treatment response and user-experience data following use of Nasal Glucagon (LY900018) in treating episodes of hypoglycem...

What is the current status of trial NCT02402933?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 26 participants. The study started on 2015-03. Estimated completion is 2015-08.

What conditions does trial NCT02402933 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Hypoglycemia.

What interventions are being tested in trial NCT02402933?

The interventions under investigation include: Nasal Glucagon (DRUG).

Who is sponsoring clinical trial NCT02402933?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02402933 being conducted?

This trial has 3 study locations across Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Hypoglycemia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.